← Back
$VRNA All transactions

Verona Pharma plc

M 10b5-1 Plan

$ Value

$77K

Shares

40,000

Price

$2

Filed

May 16

Insider

Name

ACKERMANN CHRISTINA

Title

CIK

0001681871

Roles

Director

Transaction Details

Transaction Date

2025-05-14

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

81,880

Footnotes

Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer. | The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into on February 12, 2025. | The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $8.3894 to $8.5688 per Ordinary Share, inclusive (or $67.115 to $68.55 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. | Consists of 41,880 Ordinary Shares represented by 5,235 ADSs. | The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer. | The option is fully vested.

Filing Info

Accession No.

0001104659-25-050043

Form Type

4

Issuer CIK

0001657312

ACKERMANN CHRISTINA's History

Date Ticker Type Value
2025-10-07 VRNA D
2025-10-07 VRNA M
2025-10-07 VRNA D
2025-10-07 VRNA M
2025-10-07 VRNA D
2025-10-07 VRNA D
2025-08-01 VRNA M $0
2025-08-01 VRNA $24K
2025-08-01 VRNA M $0
2025-05-14 VRNA M $77K

Other Insiders at VRNA (90d)

No other insider activity at this issuer in the last 90 days.